Current filters:


Popular Filters

6726 to 6750 of 6945 results

Vifor Pharma ties up with Hikma for Ferinject in Middle East and North Africa


Switzerland-based Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), has entered into a collaboration…

FerinjectFinancialGalenicaHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldVifor Pharma

10% drop in overall disbursements for AIDS response in 2010, as seven out of 15 governments report reductions


Funding disbursements from donor governments for the AIDS response in low- and middle-income countries…


Forest Labs repurchases $350 million additional shares


US drugmaker Forest Laboratories (NYSE: FRX), which is an ongoing battle with billionaire investor Carl…

FinancialForest LaboratoriesPharmaceutical

Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission


A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic…


BMI ups forecast for Swedish pharmaceuticals market


While Sweden boasts one of the most admirable economies in the world, its pharmaceutical market is not…

EuropeMarkets & MarketingPharmaceutical

Pfizer wins case to stop Teva selling generic Viagra in USA


Global pharmaceutical behemoth Pfizer (NYSE: PFE) revealed yesterday that it has prevailed in its patent…

GenericsLegalNorth AmericaPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

Gilead’s investigational Quad HIV regimen meets primary endpoint in Pivotal Ph III study


US biotech Gilead Sciences (Nasdaq: GILD) yesterday announced positive results from a Phase III clinical…

Anti-viralsBiotechnologyGilead SciencesPharmaceuticalResearch

Positive top-line Ph III results of Impax and GSK IPX066 in advanced Parkinson’s disease


USA-based Impax Pharmaceuticals, the branded products division of Impax Laboratories, (Nasdaq: IPXL),…

GlaxoSmithKlineImpax LaboratoriesNeurologicalPharmaceuticalResearch

Pharming extends Ruconest deal with SOBI


Netherlands-based biotech firm Pharming Group NV (Euronext: PHARM) has extended its existing agreement…

BiotechnologyEuropeLicensingPharmaceuticalPharmingRare diseasesRest of the WorldRhucinRuconestSwedish Orphan Biovitrum

Chugai gets rights to Roche melanoma drug vemurafenib in Japan


Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) said yesterday that it has entered into a license…

Chugai PharmaceuticalLicensingOncologyPharmaceuticalRochevemurafenib

Pulmatrix to focus on COPD and cystic fibrosis clinical programs


US drug developer Pulmatrix say that its clinical development plans will focus on the company’s…

FinancialPharmaceuticalPulmatrixResearchRespiratory and Pulmonary

Bayer makes moxifloxacin available to help WHO TB program in China


Bayer HealthCare, a unit of Germany’s Bayer AG (BAY: DE), has agreed to support the World Health…

Antibiotics and Infectious diseasesAsia-PacificBayerMarkets & MarketingMoxifloxacinPharmaceutical

US FDA signs deal to advance regulatory science with Arkansas state


An agreement to establish a virtual Center of Excellence for Regulatory Science was signed last week…

BiotechnologyNorth AmericaPharmaceuticalRegulationResearch

Pharma contract manufacturing revenues to reach $64.07 billion in 2016, says Visiongain


The global contract manufacturing sector will generate revenues of $64.07 billion in 2016, according…

GenericsGlobalMarkets & MarketingPharmaceutical

South Korea to cut pharma prices by average 17% to save $1.94 billion


In a move that is likely to curb current growth prospects for the pharmaceutical industry in South Korea,…


Novartis' imatinib patent battle resumes in Indian Supreme Court


The controversial Novartis case in which the Swiss major Novartis (NOVN: VX) challenged the manner in…


Shionogi completes new $247 million research facility


Japanese drug major Shionogi (TKO: 4507)last week held an inauguration ceremony of the new pharmaceutical…


USA has one of least cost-effective health care systems in world, according to new study


The USA has finished near the bottom of a study conducted that sought to compare how its health care…


Sub-Saharan group says legal and policy barriers to HIV should be confronted


In Sub-Saharan Africa, the region most heavily affected by HIV, legal, policy and social barriers, including…

Anti-viralsLegalPharmaceuticalPoliticsRest of the World

Oral anti-diabetic drug adherence among Medicare Part D beneficiaries improved by mail services; study


Findings from a new study published on-line in the Journal of Medical Economics suggest that, in the…

DiabetesMarkets & MarketingNorth AmericaPharmaceutical

US life sciences VC deals up in value but down 9% in volume


Venture capitalists in the USA invested $5.9 billion in 736 deals in the first quarter of 2011, according…

BiotechnologyFinancialNorth AmericaPharmaceutical

Teijin and Astellas expand collaboration on gout drug febuxostat


Japanese drugmakers Teijin Pharma (TYO: 3401 and Astellas Pharma (TKO:4503) have entered into an exclusive…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmafebuxostatLicensingPharmaceuticalTeijin

6726 to 6750 of 6945 results

Back to top